Saturday, October 31, 2026

Nuveen Multi And 3 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

August 12, 2021

Nuveen Multi And 3 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Nuveen Multi (JMM), TCG BDC (CGBD), City Holding Company (CHCO) are the highest payout ratio stocks on this list.

Here's the data we've collected of stocks with a high payout ratio so far. The payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Nuveen Multi (JMM)

243.85% Payout Ratio

Nuveen Multi-Market Income Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.

Volume

Today's last reported volume for Nuveen Multi is 937, 86.65% below its average volume of 7022.

As maintained by Morningstar, Inc., the next dividend payment is on Jul 13, 2021, the estimated forward annual dividend rate is 0.36 and the estimated forward annual dividend yield is 4.8%.

Year-on-year quarterly revenue growth declined by 21.4%, now sitting on 3.99M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 1.67%.

Volatility

Nuveen Multi's last day, week, and month's current volatility was 0.27%, 0.27%, and 0.41%, respectively.

Nuveen Multi's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.40% (day), 0.62% (last week), and 0.92% (last month), respectively.

Nuveen Multi's Stock Yearly Top and Bottom Value

Nuveen Multi's stock is valued at $7.50 at 20:23 EST, below its 52-week high of $7.71 and way higher than its 52-week low of $6.42.

Nuveen Multi's Moving Average

Nuveen Multi's value is higher than its 50-day moving average of $7.47 and higher than its 200-day moving average of $7.32.

2. TCG BDC (CGBD)

47.5% Payout Ratio

TCG BDC, Inc. is a non-diversified closed-end investment company.

Volume

Today's last reported volume for TCG BDC is 147778, 31.45% below its average volume of 215593.

As claimed by Morningstar, Inc., the next dividend payment is on Jun 28, 2021, the estimated forward annual dividend rate is 1.28 and the estimated forward annual dividend yield is 9.38%.

TCG BDC's sales growth this year is anticipated to be negative 10.6% and 1.4% for next year.

Year-on-year quarterly revenue growth declined by 19.2%, now sitting on 172.42M for the twelve trailing months.

TCG BDC's sales growth is negative 10.9% for the present quarter and negative 5.6% for the next. The company's growth estimates for the current quarter and the next is negative 5.3% and 8.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.17%.

Volatility

TCG BDC's last day, week, and month's current volatility was 1.23%, 1.55%, and 0.93%, respectively.

TCG BDC's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.16% (day), 1.96% (last week), and 1.91% (last month), respectively.

TCG BDC's Stock Yearly Top and Bottom Value

TCG BDC's stock is valued at $14.20 at 20:23 EST, under its 52-week high of $14.22 and way above its 52-week low of $7.98.

TCG BDC's Moving Average

TCG BDC's worth is above its 50-day moving average of $13.44 and above its 200-day moving average of $13.17.

3. City Holding Company (CHCO)

43.31% Payout Ratio

City Holding Company operates as a holding company for City National Bank of West Virginia that provides various banking, trust and investment management, and other financial solutions in the United States.

Volume

Today's last reported volume for City Holding Company is 49649, 20.59% below its average volume of 62528.

According to Morningstar, Inc., the next dividend payment is on Jul 13, 2021, the estimated forward annual dividend rate is 2.32 and the estimated forward annual dividend yield is 3.1%.

City Holding Company's sales growth this year is expected to be negative 8.2% and 1.4% for next year.

Year-on-year quarterly revenue growth grew by 11.5%, now sitting on 221.34M for the twelve trailing months.

City Holding Company's sales growth for the current quarter is 2.1%. The company's growth estimates for the present quarter and the next is 3.6% and negative -8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.14%.

Volatility

City Holding Company's last day, week, and month's current volatility was 2.24%, 1.19%, and 1.23%, respectively.

City Holding Company's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.36% (day), 1.74% (last week), and 2.23% (last month), respectively.

City Holding Company's Stock Yearly Top and Bottom Value

City Holding Company's stock is valued at $78.34 at 20:23 EST, way below its 52-week high of $88.49 and way above its 52-week low of $55.03.

City Holding Company's Moving Average

City Holding Company's worth is higher than its 50-day moving average of $75.11 and higher than its 200-day moving average of $77.60.

4. NBT Bancorp (NBTB)

35.41% Payout Ratio

NBT Bancorp Inc., a financial holding company, provides commercial banking, retail banking, and wealth management services.

As claimed by Morningstar, Inc., the next dividend payment is on May 27, 2021, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 2.89%.

Year-on-year quarterly revenue growth grew by 43.3%, now sitting on 446.74M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.62%.

Volatility

NBT Bancorp's last day, week, and month's current volatility was 1.44%, 1.16%, and 1.49%, respectively.

NBT Bancorp's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.51% (day), 2.10% (last week), and 2.80% (last month), respectively.

NBT Bancorp's Stock Yearly Top and Bottom Value

NBT Bancorp's stock is valued at $0.00 at 20:23 EST, below its 52-week low of $26.10.

NBT Bancorp's Moving Average

NBT Bancorp's value is under its 50-day moving average of $35.02 and under its 200-day moving average of $37.45.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com